You can buy or sell Conatus and other stocks, options, ETFs, and crypto commission-free!
Conatus Pharmaceuticals Inc. Common Stock, also called Conatus, is a biotechnology company, which engages in the development and commercialization of medicines for the treatment of liver diseases. Read More It focuses in development of emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
-$0.10 per share